LNTH vs RLAY
Lantheus Holdings vs Relay Therapeutics, Inc. — AI-powered side-by-side comparison
LNTH
Lantheus Holdings
67
Buy
VS
RLAY
Relay Therapeutics, Inc.
65
Buy
| Metric | LNTH | RLAY |
|---|
| AI Score |
67
|
65
|
| Price |
$100.63
|
$20.00
|
| P/E Ratio |
23.91×
|
-12.73×
|
| ROE |
21.4%
|
-48.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
60.1%
|
-566.6%
|
| Debt / Equity |
0.44×
|
0.03×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
42.5
|
66.0
|
| Beta |
-0.057
|
1.704
|
| Expected Upside |
+7.8%
|
—
|
AI Committee View
Current Innellis committee reasoning for LNTH versus RLAY.
LNTH leads by 2 points.
LNTH scores 67/100 (Buy) versus RLAY at 65/100 (Buy).
LNTH Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
RLAY Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is roe of only -42.3% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -42.3% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical